R&D CENTER
API company’s R&D center drives innovation in process chemistry, synthetic and analytical development, and technology optimization.
It advances scalable, cost-effective routes for new and existing active pharmaceutical ingredients while ensuring regulatory compliance, quality control, and seamless technology transfer from laboratory to commercial production.
API DEVELOPMENT:
Development of methods for the synthesis of APIs
Standardization of API quality indicators according to ICH
Development of synthesis technology to manufacture APIs
Study of stability & forced degradation of APIs
MANUFACTURING
Manufacturing cytotoxic APIs using advanced techniques and isolators involves synthesizing highly potent compounds within controlled, contained environments.
Specialized isolators with stringent containment and automation protect operators and product integrity while minimizing contamination and exposure. These systems support precision processes under regulatory standards, enhancing safety, quality, and efficiency in HPAPI production.
